Keller Rohrback L.L.P. Investigates Life-Threatening Complications From Xarelto Drug Use

        Print
| Source: Keller Rohrback L.L.P.

SEATTLE, Aug. 25, 2014 (GLOBE NEWSWIRE) -- Attorney Advertising. The blood-thinning drug Xarelto is under scrutiny for causing uncontrollable bleeding, and attorneys at Keller Rohrback L.L.P. are investigating possible wrongful deaths and injuries that patients and their families have suffered as a result. Xarelto is a novel drug used to treat clot-related problems stemming from deep vein thrombosis and atrial fibrillation. Xarelto is touted as one-size-fits-all medication, alleviating the need for patients to undergo testing to ensure their blood is thinned enough, but not too much.

"Xarelto's claim that patients don't need to be tested can be dangerous, because without testing, you don't know how thin your blood is and whether you are in the 'goldilocks' range of anti-coagulation," said Daniel Mensher, a Keller Rohrback attorney. "While the no-testing claims are great for the company's marketing department, taking this drug without adequate testing is simply too risky."

Recently, the British Medical Journal noted that Xarelto and other novel anti-coagulants can produce a wide range of responses between individual patients, and as a result require closer individualized testing and dose adjustment for each patient, just as with the traditional blood thinner, Warfarin. But, unlike Warfarin, Xarelto has no known antidote if a case of uncontrolled bleeding occurs. As such, millions of Americans using the drug without adequate testing are potentially at risk.

Individuals who have taken Xarelto, as well as their families, who are interested in our investigation may contact Keller Rohrback attorneys Daniel Mensher, Gretchen Cappio or Mark Samson at (800) 776-6044 or info@kellerrohrback.com to find out more information about any potential claims they may have regarding Xarelto.

Keller Rohrback has a long history of protecting people, and has successfully represented hundreds of clients injured by prescription drugs, such as Fen-Phen, Baycol, and Vioxx. With offices in Seattle, Phoenix, New York, and Santa Barbara, our Complex Litigation Group is proud to offer its expertise in personal injury cases to clients nationwide.

Attorney Advertising. Prior Results Do Not Guarantee A Similar Outcome.

Keller Rohrback L.L.P.
Gretchen Cappio or Daniel Mensher
Attorneys
(800) 776-6044

www.krcomplexlit.com